Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
An Emerging Name in Cannabis: HERB (click to learn more) AI-Driven Wellness Play on the CSE (click to learn more) Golden Cariboo (CSE:GCC) (OTC:GCCFF) Unlocks Cariboo Gold Potential (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News Eastgate Biotech Corporation (EM) ETBI

Healthcare Biotechnology
Eastgate Biotech Corp., a development stage company, develops novel formulations of natural compounds and pharmaceutical products. The company is developing pharmaceutical products, such as Lorazepam oral spray for acute seizures emergency treatment; Ketoconazole 2% topical ointment for treatment of skin fungal infections; and Metformin chewable/ sublingual tablets for treatment of type 2... see more

Recent & Breaking News (EXPM:ETBI)

EastGate Biotech Corp. Enters Into a 3-way International Distribution Agreement With Dr. Upadhyay Vedic Research Laboratories and ImmunoJuvenate, Inc.

GlobeNewswire May 17, 2021

EastGate Biotech Corp. Enters into a Licensing and Distribution Agreement for Glucora, One of Its Nutraceutical Products for the US, Canadian, Central and South American Markets

GlobeNewswire March 8, 2021

EastGate Biotech Pakistan Expands its Collaboration in Advancing the Development of a New Vaccine Against COVID-19

GlobeNewswire February 18, 2020

EastGate Biotech Discusses Their Phase 3 Clinical Trials and Recent Coronavirus Agreement

Newsfile February 5, 2020

EastGate Biotech Pakistan Receives International Marketing Rights of Anaferon an Approved Coronavirus Treatment to Potentially Combat the Wuhan Coronavirus

GlobeNewswire January 30, 2020

EastGate Biotech Provides Summary of 2019 Corporate and Development Highlights

GlobeNewswire December 30, 2019

EastGate Biotech Expands Pipeline to Alzheimer's Disease Using its Alternative Insulin Delivery Platform

GlobeNewswire November 14, 2019

EastGate Biotech Announces Expansion and Restructuring of Joint Venture with its Partner in Pakistan

GlobeNewswire October 9, 2019

EastGate Biotech Receives Regulatory Approval to Initiate a Phase III 90-day Clinical Trial on Insugin, Its Liquid Insulin Mouth Rinse Solution

GlobeNewswire September 25, 2019

EastGate Biotech Announces Appointment of Bill Abajian to Lead Licensing and Marketing Phase as Chief Operating Officer

GlobeNewswire September 4, 2019

EastGate Biotech Files Application to Initiate Phase III Clinical Trial for Insugin

GlobeNewswire June 26, 2019

Bill Abajian of EastGate Biotech Corp. to Speak at the 2019 M&A Forum for Pharma, Biotech, and Med Device to be Held Between August 12-14, 2019 in Philadelphia

GlobeNewswire June 12, 2019

EastGate Biotech Announces Preparation to Initiate Phase III Clinical Trials on Insugin, its Liquid Insulin Mouth Rinse for Type 2 Diabetes Patients

GlobeNewswire May 15, 2019

EastGate Biotech Announces Positive Phase II Clinical Results of its Innovative Liquid Insulin Mouth Rinse Solution for Type 2 Diabetes

GlobeNewswire April 24, 2019

EastGate Biotech Signs Strategic Alliance Agreement with MJ Biopharm for Insulin API Supply

GlobeNewswire March 19, 2019

EastGate Biotech Attends Arab Health Conference Seeking Additional Joint Venture Partnerships

GlobeNewswire January 30, 2019

EastGate Biotech Appoints Additional Consultants in Preparation of Progressing Company Developments in 2019

GlobeNewswire December 19, 2018

EastGate Biotech Appoints World-Renowned Diabetes Key Opinion Leader Dr. Lalit Upadhyay for Upcoming Initiatives

ACCESS Newswire November 19, 2018

EastGate Biotech Receives Approval to Commence a Phase 2 Trial for Liquid Insulin Mouth Rinse Solution Addressing Patient Compliance in the Type 2 Diabetes Market

ACCESS Newswire October 3, 2018

EastGate Biotech Signs Definitive Investment and European Licensing Agreement With Nico Innovagroup S.r.l. for Liquid Insulin Mouth Rinse Solution

ACCESS Newswire August 27, 2018

Podcasts